OBJECTIVES: Myocardial adenosine is increased in pressure-overload hypertrophy (POH) and exerts important cardioprotective effects that delay transition to left ventricular failure. Adenosine-mediated signaling is attenuated in POH, but whether this depends on receptor or postreceptor defects is unknown. We therefore examined left ventricular adenosine A1-receptor gene and protein expression in experimental POH. METHODS: Six week-old Sprague-Dawley rats were subjected to abdominal aortic banding (group B) or sham operation (group S). Echocardiography and left ventricular catheterization were performed 10 weeks later under ketamine anesthesia. Left ventricular and lung weight indices were obtained postmortem. A1-Receptor mRNA and protein expression were measured in samples from left ventricular, right ventricular and aortic arch tissue. Group B rats were subgrouped as having compensated or decompensated hypertrophy according to the absence or presence of lung congestion (lung weight index below or above mean +/- 2SD compared with group S rats). RESULTS: Both mRNA and protein A1-receptor expression were significantly increased in compensated group B versus group S rats (by, respectively, 37 and 77%; both P < 0.01). This was not observed in decompensated group B rats. No consistent gene or receptor expression changes were observed in right ventricular or aortic tissues. CONCLUSIONS: In compensated POH, increased interstitial adenosine concentrations are accompanied by increased expression of the specific receptor mediating the major cardioprotective effects of this autacoid. Such overexpression is no longer detectable once the transition from POH to left ventricular failure has occurred. These observations may have pathophysiological and, in perspective, therapeutic relevance to the course of hypertensive heart disease.

Adenosine A1 receptor expression during the transition from compensated pressure overload hypertrophy to heart failure.

PERLINI, STEFANO;PALLADINI, GIUSEPPINA;
2007-01-01

Abstract

OBJECTIVES: Myocardial adenosine is increased in pressure-overload hypertrophy (POH) and exerts important cardioprotective effects that delay transition to left ventricular failure. Adenosine-mediated signaling is attenuated in POH, but whether this depends on receptor or postreceptor defects is unknown. We therefore examined left ventricular adenosine A1-receptor gene and protein expression in experimental POH. METHODS: Six week-old Sprague-Dawley rats were subjected to abdominal aortic banding (group B) or sham operation (group S). Echocardiography and left ventricular catheterization were performed 10 weeks later under ketamine anesthesia. Left ventricular and lung weight indices were obtained postmortem. A1-Receptor mRNA and protein expression were measured in samples from left ventricular, right ventricular and aortic arch tissue. Group B rats were subgrouped as having compensated or decompensated hypertrophy according to the absence or presence of lung congestion (lung weight index below or above mean +/- 2SD compared with group S rats). RESULTS: Both mRNA and protein A1-receptor expression were significantly increased in compensated group B versus group S rats (by, respectively, 37 and 77%; both P < 0.01). This was not observed in decompensated group B rats. No consistent gene or receptor expression changes were observed in right ventricular or aortic tissues. CONCLUSIONS: In compensated POH, increased interstitial adenosine concentrations are accompanied by increased expression of the specific receptor mediating the major cardioprotective effects of this autacoid. Such overexpression is no longer detectable once the transition from POH to left ventricular failure has occurred. These observations may have pathophysiological and, in perspective, therapeutic relevance to the course of hypertensive heart disease.
2007
Medical Research, Organs & Systems includes resources dealing with the normal and disease states of single organs, tissues, or single physiological systems, exclusive of the heart, vascular and immune systems. Systems covered here include hepatology, pulmonary function/physiology, gastroenterology, otolaryngology, respiratory system, andrology, gynecology and reproduction, dermatology, and dentistry/odontology. Resources dealing with general physiology, classes of disease that immediately affect many or all body systems, and medical research focused on specific types of medical intervention are excluded.
Sì, ma tipo non specificato
Inglese
Internazionale
STAMPA
24
2
449
454
In base al "subject category" ISI: PERIPHERAL VASCULAR DISEASE del 2007 la rivista è in posizione 9/54 per impact factor la rivista è in posizione 10/54 per citazioni totali. Tematica Ex SIR: Alterato legame tra cardiomiociti ed interstizio miocardico come base della dilatazione ventricolare: studio della cardiomiopatia dilatativa e di quella diabetico-ipertensiva (Classif. Ex SIR:Articoli su riviste ISI )
Animals Disease Models; Animal Heart Failure; Congestive/genetics/ physiopathology Hypertrophy; Left Ventricular/genetics/ metabolism Male RNA; Messenger/analysis/metabolism Rats Rats; Sprague-Dawley Receptor; Adenosine A1/genetics/ metabolism Ventricular Pressure/physiology
http://www.ncbi.nlm.nih.gov/pubmed/17211253
10
info:eu-repo/semantics/article
262
Perlini, Stefano; Palladini, Giuseppina; Arosio, B.; Parmeggiani, L.; Santambrogio, D.; Tozzi, R.; Gatti, C.; Annoni, G.; Meyer, T. E.; Ferrari, A. U....espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/32941
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 5
social impact